Hester Biosciences zooms 33% in 2 days as firm in talks to produce Covaxin

The company said it has tied up with the Gujarat government to explore the production of Covid-19 vaccine through technology transfer from Bharat Biotech

Shares of Hester Biosciences rallied 19 per cent to Rs 2,944 on the BSE in intra-day trade on Monday, up 33 per cent in the past two trading days, after the pharmaceutical company said it has tied up with the Gujarat government to explore the production of Covid-19 vaccine through technology transfer from Bharat Biotech. 

The Ahmedabad-based firm said it has already initiated discussions with Bharat Biotech in this regard. The stock was trading at its all-time high level on the BSE.

“A triparty consortium has been formed with the government of Gujarat as the lead partner, to explore the prospects of